Exclusive enteral nutrition with a polymeric diet is efficacious in inducing remission in adults with active Crohn's disease
No Thumbnail Available
File version
Author(s)
Ramaswamy, Pradeep Kakkadasam
Mutsekwa, Rumbidzai
Lan, Xiao
Angus, Rebecca
Chen, Yvonne
Moattar, Hadi
Edwards, John
Shukla, Dheeraj
Mutsekwa, Rumbidzai
Lan, Xiao
Angus, Rebecca
Chen, Yvonne
Moattar, Hadi
Edwards, John
Shukla, Dheeraj
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2020
Size
File type(s)
Location
License
Abstract
Background: We aimed to describe the real-world effectiveness and safety of the oral JAK inhibitor tofacitinib (tofa) in Crohn's disease (CD). Methods: We analyzed a retrospective, multi-center cohort from 3 IBD referral centers in the United States. CD pts started on tofa for active disease were included. The primary outcome was clinical response (> 50% reduction in symptoms) at week 8 determined by physician global assessment. Secondary outcomes included clinical remission at week 8. Adverse events (AEs) were recorded. Abnormal lipid..
Journal Title
Conference Title
Gastroenterology
Book Title
Edition
Volume
Issue
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Clinical sciences
Neurosciences
Science & Technology
Life Sciences & Biomedicine
Gastroenterology & Hepatology
Neurosciences
Science & Technology
Life Sciences & Biomedicine
Gastroenterology & Hepatology
Persistent link to this record
Citation
Ramaswamy, PK; Mutsekwa, R; Lan, X; Angus, R; Chen, Y; Moattar, H; Edwards, J; Shukla, D, Exclusive enteral nutrition with a polymeric diet is efficacious in inducing remission in adults with active Crohn's disease, Gastroenterology, 2020, 158 (6), pp. S1210-S1211